Cantrell Drug Recalls Heparin Sodium Syringes Due to Sterility Concerns
Cantrell Drug Company is recalling 1,494 syringes of Heparin Sodium due to a lack of assurance of sterility. The products were distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for drug recalls involving potential sterility issues.
Plain-English summary
Cantrell Drug Company is recalling 1,494 single-dose syringes of Heparin Sodium, 1 USP Unit/2 mL (0.5 USP Units/mL) in 0.45% Sodium Chloride. The recall is being conducted because the firm lacks assurance of the sterility of the drug products.
The affected product is identified by Lot 9220 and NDC 52533-148-16. These syringes are intended for hospital and office use only and are prescription-only items. The recall covers products distributed nationwide.
Healthcare facilities and pharmacies should stop using the affected syringes and contact Cantrell Drug Company for further instructions. Consumers should not use these products and should consult their healthcare provider if they have questions regarding their use.
The recalled product
- Product
- Heparin Sodium, 1 USP Unit/2 mL (0.5 USP Units/mL) in 0.45% Sodium Chloride, Single-Dose Syringe, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207, NDC 52533-148-16
- Manufacturer
- Cantrell Drug Company
- Category
- Drug — Injectable Sterile Drug
- Affected units
- 1,494
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 9220
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 21 recalled by Cantrell Drug Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 21 products in this recall →Related recalls
Same manufacturer · Cantrell Drug Company
See all →- SevereCantrell Drug Company Recalls Rocuronium Bromide Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Succinylcholine Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Norepinephrine Bags Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Recalls Neostigmine Methylsulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- ModerateCantrell Drug Recalls Heparin Sodium Syringes Due to Stability Data Concerns
FDA (Drugs) · 2016-07-13
- ModerateCantrell Drug Recalls Heparin Sodium Syringes Due to Stability Data Issues
FDA (Drugs) · 2016-07-13
- SevereCantrell Drug Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Phenylephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Company Recalls Ephedrine Sulfate Injection Syringes
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Adenosine Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-08-16